| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 07/28/2026 | ±2.2% | +4.0% | under-priced |
| 04/28/2026 | ±2.0% | -4.5% | under-priced |
| 02/25/2026 | ±1.9% | +0.1% | over-priced |
| 10/28/2025 | ±1.3% | +0.7% | over-priced |
| 07/31/2025 | ±1.4% | +10.7% | under-priced |
| 04/29/2025 | ±2.7% | +2.3% | over-priced |
| 03/03/2025 | ±1.6% | -0.8% | over-priced |
| 10/31/2024 | ±1.4% | -6.5% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | $1.11 | $2.3B | $263M |
| Q1 FY2026 | $0.79 | $2.1B | $193M |
| Q4 FY2025 | — | $2.4B | $335M |
| Q3 FY2025 | $0.93 | $2.3B | $227M |
XYL (XYL) reports in 89 days, with the next report estimated for 01/25/2027. Across the last 8 reports, options priced an average ±1.8% earnings move while the stock actually moved 3.7% on average — the market has been roughly fair on XYL's earnings risk. Fundamentals into the print: EPS up 19.4% year-over-year, revenue up 1.5%. QuantLogix's live 5-factor engine currently reads XYL as a underweight at 17/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →